Lethal Mutagenesis of RNA Viruses and Approved Drugs with Antiviral Mutagenic Activity
In RNA viruses, a small increase in their mutation rates can be sufficient to exceed their threshold of viability. Lethal mutagenesis is a therapeutic strategy based on the use of mutagens, driving viral populations to extinction. Extinction catastrophe can be experimentally induced by promutagenic...
Main Authors: | Ikbel Hadj Hassine, Manel Ben M’hadheb, Luis Menéndez-Arias |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/4/841 |
Similar Items
-
Favipiravir elicits antiviral mutagenesis during virus replication in vivo
by: Armando Arias, et al.
Published: (2014-10-01) -
Favipiravir: the hidden threat of mutagenic action
by: O. P. Zhirnov, et al.
Published: (2021-05-01) -
Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
by: Jennifer Mayor, et al.
Published: (2021-06-01) -
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues
by: Robert J. Geraghty, et al.
Published: (2021-04-01) -
Favipiravir Inhibits Hepatitis A Virus Infection in Human Hepatocytes
by: Reina Sasaki-Tanaka, et al.
Published: (2022-02-01)